Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 13, Issue 10

2021 May-2 - 223 articles

Cover Story: Cancer immunotherapies have altered the treatment landscape significantly in several cancers, yet not enough for many cancer patients. T cell co-stimulation is an alternative immunotherapy approach to activate cytotoxic T cells in the tumor and can be combined with other immunotherapies, including checkpoint inhibitors to enhance and maintain T cell activities. Among T cell co-stimulatory receptors in the TNFRSF, CD137 appears to be most promising target based on the available clinical data. In the current issue, Hashimoto reviewed the biology of CD137 and clinical data of CD137 targeting compounds. The author acknowledged that the recent technological advances maintain potency without compromising safety yet understanding the biology of CD137 is the key to the success of the development of CD137 targeting compounds. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (223)

  • Article
  • Open Access
37 Citations
7,577 Views
23 Pages

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer

  • Anne Gallez,
  • Silvia Blacher,
  • Erik Maquoi,
  • Erika Konradowski and ,
  • Marc Joiret,
  • Irina Primac,
  • Céline Gérard,
  • Mélanie Taziaux,
  • René Houtman and
  • Christel Péqueux
  • + 11 authors+ 6 authors

20 May 2021

Given the unequivocal benefits of menopause hormone therapies (MHT) and combined oral contraceptives (COC), there is a clinical need for new formulations devoid of any risk of breast cancer promotion. Accumulating data from preclinical and clinical s...

(This article belongs to the Special Issue Nuclear Receptors and Cancer)
  • Article
  • Open Access
2 Citations
4,557 Views
19 Pages

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy

  • Chao Gao,
  • Guangxu Jin,
  • Elizabeth Forbes,
  • Lingegowda S. Mangala and ,
  • Yingmei Wang,
  • Cristian Rodriguez-Aguayo,
  • Paola Amero,
  • Emine Bayraktar,
  • Ye Yan and
  • Wei Zhang
  • + 9 authors+ 4 authors

20 May 2021

IK is a mitotic factor that promotes cell cycle progression. Our previous investigation of 271 endometrial cancer (EC) samples from the Cancer Genome Atlas (TCGA) dataset showed IK somatic mutations were enriched in a cluster of patients with high-gr...

(This article belongs to the Special Issue Cellular Plasticity and the Untapped Therapeutic Potential in Cancer)
  • Article
  • Open Access
7 Citations
4,443 Views
12 Pages

Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

  • Sazan Rasul,
  • Tim Wollenweber,
  • Lucia Zisser,
  • Elisabeth Kretschmer-Chott and ,
  • Bernhard Grubmüller,
  • Gero Kramer,
  • Shahrokh F. Shariat,
  • Harald Eidherr,
  • Markus Mitterhauser and
  • Alexander R. Haug
  • + 8 authors+ 3 authors

20 May 2021

Background: We investigated the response rate and degree of toxicity of a second course of three cycles of [177Lu]Lu-PSMA radioligand therapy (PSMA-RLT) every 4 weeks in mCRPC patients. Methods: Forty-three men (71.5 ± 6.6 years, median PSA 40.8 (0.8...

(This article belongs to the Special Issue Urological Cancer 2021)
  • Review
  • Open Access
15 Citations
6,379 Views
15 Pages

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy

  • Hiroko Ishii,
  • Said M. Afify,
  • Ghmkin Hassan,
  • David S. Salomon and
  • Masaharu Seno

20 May 2021

The immune system has been found to be suppressed in cancer patients. Cancer cells are extremely resistant to chemotherapeutic drugs, conventional immunotherapy, or cancer antigen vaccine therapy. Cancer immunotherapy, which is mainly based on immune...

(This article belongs to the Special Issue The Portrait of Cancer Immunotherapy: Tumor Microenvironment, Biomarkers and Immune Resistance)
  • Article
  • Open Access
13 Citations
5,853 Views
12 Pages

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

  • Christoph Suppan,
  • Florian Posch,
  • Hannah Deborah Mueller,
  • Nina Mischitz and ,
  • Daniel Steiner,
  • Eva Valentina Klocker,
  • Lisa Setaffy,
  • Ute Bargfrieder,
  • Robert Hammer and
  • Marija Balic
  • + 9 authors+ 4 authors

20 May 2021

Background: The prognostic performance of the residual cancer burden (RCB) score is a promising tool for breast cancer patients undergoing neoadjuvant therapy. We independently evaluated the prognostic value of RCB scores in an extended validation co...

(This article belongs to the Special Issue Neoadjuvant Systemic Therapy in Early Breast Cancer)
  • Article
  • Open Access
25 Citations
5,948 Views
21 Pages

Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells

  • Jerneja Kladnik,
  • James P. C. Coverdale,
  • Jakob Kljun,
  • Hilke Burmeister and ,
  • Petra Lippman,
  • Francesca G. Ellis,
  • Alan M. Jones,
  • Ingo Ott,
  • Isolda Romero-Canelón and
  • Iztok Turel
  • + 5 authors+ 0 author

20 May 2021

Drug resistance to existing anticancer agents is a growing clinical concern, with many first line treatments showing poor efficacy in treatment plans of some cancers. Resistance to platinum agents, such as cisplatin, is particularly prevalent in the...

(This article belongs to the Special Issue New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104))
  • Article
  • Open Access
3 Citations
3,702 Views
14 Pages

Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer

  • Shih-Min Lin,
  • Hsiu-Ying Ku,
  • Che-Yu Hsu,
  • Chih-Liang Wang and ,
  • Gee-Chen Chang,
  • Cheng-Shyong Chang and
  • Tsang-Wu Liu
  • + 2 authors+ 0 author

20 May 2021

(1) Purpose: To investigate the effects of the time interval between initiation of adjuvant chemotherapy and radiotherapy on survival outcomes in patients with completely resected stage IIIA pN2 non-small-cell lung cancer (NSCLC); (2) Methods: Data o...

  • Feature Paper
  • Review
  • Open Access
50 Citations
10,059 Views
20 Pages

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy

  • Kazuhiko Matsuo,
  • Osamu Yoshie,
  • Kosuke Kitahata,
  • Momo Kamei and ,
  • Yuta Hara and
  • Takashi Nakayama
  • + 1 author+ 0 author

20 May 2021

Cancer immunotherapy aims to treat cancer by enhancing cancer-specific host immune responses. Recently, cancer immunotherapy has been attracting much attention because of the successful clinical application of immune checkpoint inhibitors targeting t...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
14 Citations
5,076 Views
29 Pages

The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy

  • Abderrahman Chargui,
  • Amine Belaid,
  • Papa Diogop Ndiaye,
  • Véronique Imbert and ,
  • Michel Samson,
  • Jean-Marie Guigonis,
  • Michel Tauc,
  • Jean-François Peyron,
  • Philippe Poujeol and
  • Baharia Mograbi
  • + 7 authors+ 2 authors

20 May 2021

Signaling, proliferation, and inflammation are dependent on K63-linked ubiquitination—conjugation of a chain of ubiquitin molecules linked via lysine 63. However, very little information is currently available about how K63-linked ubiquitination is s...

  • Systematic Review
  • Open Access
17 Citations
3,545 Views
14 Pages

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis

  • Mario Pones,
  • David D’Andrea,
  • Keiichiro Mori,
  • Mohammad Abufraj and ,
  • Marco Moschini,
  • Eva Comperat and
  • Shahrokh F. Shariat
  • + 2 authors+ 0 author

20 May 2021

To evaluate oncological outcomes of primary versus secondary muscle-invasive bladder cancer treated with radical cystectomy. Medline, Embase, Scopus and Cochrane Library were searched for eligible studies. Hazard ratios for overall survival (OS), can...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
22 Citations
6,320 Views
18 Pages

20 May 2021

Genetically altered stem or progenitor cells feature gross chromosomal abnormalities, inducing modified ability of self-renewal and abnormal hematopoiesis. Cyclin-dependent kinases (CDK) regulate cell cycle progression, transcription, DNA repair and...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
8 Citations
3,824 Views
16 Pages

Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma

  • Lisanne Noordam,
  • Zhouhong Ge,
  • Hadiye Özturk,
  • Michail Doukas and ,
  • Shanta Mancham,
  • Patrick P. C. Boor,
  • Lucia Campos Carrascosa,
  • Guoying Zhou,
  • Thierry P. P. van den Bosch and
  • Jaap Kwekkeboom
  • + 9 authors+ 4 authors

20 May 2021

High recurrence rates after resection of hepatocellular carcinoma (HCC) with curative intent impair clinical outcomes of HCC. Cancer/testis antigens (CTAs) are suitable targets for cancer immunotherapy if selectively expressed in tumor cells. The aim...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
80 Citations
16,105 Views
24 Pages

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs

  • Cristina Capuano,
  • Chiara Pighi,
  • Simone Battella,
  • Davide De Federicis and ,
  • Ricciarda Galandrini and
  • Gabriella Palmieri
  • + 1 author+ 0 author

20 May 2021

Natural killer (NK) cells hold a pivotal role in tumor-targeting monoclonal antibody (mAb)-based activity due to the expression of CD16, the low-affinity receptor for IgG. Indeed, beyond exerting cytotoxic function, activated NK cells also produce an...

(This article belongs to the Special Issue Antibodies in Cancer Treatment)
  • Article
  • Open Access
6 Citations
3,538 Views
10 Pages

Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?

  • August Sigle,
  • Cordula A. Jilg,
  • Timur H. Kuru,
  • Nadine Binder and ,
  • Jakob Michaelis,
  • Markus Grabbert,
  • Wolfgang Schultze-Seemann,
  • Arkadiusz Miernik,
  • Christian Gratzke and
  • Rodrigo Suarez-Ibarrola
  • + 6 authors+ 1 author

20 May 2021

Background: Systematic biopsy (SB) according to the Ginsburg scheme (GBS) is widely used to complement MRI-targeted biopsy (MR-TB) for optimizing the diagnosis of clinically significant prostate cancer (sPCa). Knowledge of the GBS’s blind sectors whe...

(This article belongs to the Special Issue Diagnosis of Prostate Cancer)
  • Article
  • Open Access
40 Citations
6,361 Views
15 Pages

Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation

  • Daniel Finke,
  • Markus B. Heckmann,
  • Janek Salatzki,
  • Johannes Riffel and ,
  • Esther Herpel,
  • Lucie M. Heinzerling,
  • Benjamin Meder,
  • Mirko Völkers,
  • Oliver J. Müller and
  • Lorenz H. Lehmann
  • + 9 authors+ 4 authors

20 May 2021

Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment. Nevertheless, their increasing use leads to an increase of immune-related adverse events (irAEs). Among them, ICI-associated myocarditis (ICIM) is a rare irAE with a high morta...

  • Review
  • Open Access
23 Citations
7,166 Views
15 Pages

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

  • Philipp Karschnia,
  • Jens Blobner,
  • Nico Teske,
  • Florian Schöberl and ,
  • Esther Fitzinger,
  • Martin Dreyling,
  • Joerg-Christian Tonn,
  • Niklas Thon,
  • Marion Subklewe and
  • Louisa von Baumgarten
  • + 5 authors+ 0 author

20 May 2021

Primary CNS lymphomas (PCNSL) represent a group of extranodal non-Hodgkin lymphomas and secondary CNS lymphomas refer to secondary involvement of the neuroaxis by systemic disease. CNS lymphomas are associated with limited prognosis even after aggres...

(This article belongs to the Special Issue Primary CNS Lymphomas: Diagnosis and Treatment)
  • Article
  • Open Access
11 Citations
5,066 Views
14 Pages

The Impact of Illness Perceptions and Coping Strategies on Use of Supportive Care for Cancer

  • Peta Stephenson,
  • Eva Yuen,
  • Gemma Skaczkowski,
  • Evelien R. Spelten and ,
  • Sheina Orbell and
  • Carlene Wilson
  • + 1 author+ 0 author

20 May 2021

Despite evidence that survivorship support programmes enhance physical and psychosocial wellbeing, cancer patients and survivors often do not use these supportive care services. This study investigated the utility of the Common Sense Model of Self-Re...

(This article belongs to the Special Issue Cancer Survivorship)
  • Article
  • Open Access
34 Citations
6,623 Views
20 Pages

Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents

  • Qing Zhou,
  • Xiotian Sun,
  • Nicolas Pasquier,
  • Parvaneh Jefferson and ,
  • Trang T. T. Nguyen,
  • Markus D. Siegelin,
  • James M. Angelastro and
  • Lloyd A. Greene
  • + 3 authors+ 0 author

20 May 2021

Transcription factors are key players underlying cancer formation, growth, survival, metastasis and treatment resistance, yet few drugs exist to directly target them. Here, we characterized the in vitro and in vivo anti-cancer efficacy of novel synth...

  • Article
  • Open Access
18 Citations
4,864 Views
20 Pages

The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination

  • Simona Serratì,
  • Letizia Porcelli,
  • Francesco Fragassi,
  • Marianna Garofoli and ,
  • Roberta Di Fonte,
  • Livia Fucci,
  • Rosa Maria Iacobazzi,
  • Antonio Palazzo,
  • Francesca Margheri and
  • Amalia Azzariti
  • + 10 authors+ 5 authors

20 May 2021

Advanced colorectal cancer (CRC) is highly metastatic and often results in peritoneal dissemination. The extracellular vesicles (EVs) released by cancer cells in the microenvironment are important mediators of tumor metastasis. We investigated the co...

(This article belongs to the Special Issue Targeting Therapy for Colon Cancer)
  • Review
  • Open Access
15 Citations
5,479 Views
14 Pages

Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment—Oncological and Surgical Perspective

  • Zuzanna Pelc,
  • Magdalena Skórzewska,
  • Karol Rawicz-Pruszyński and
  • Wojciech P. Polkowski

20 May 2021

Gastric cancer (GC) continues to be one of the major oncological challenges on a global scale. The role of neoadjuvant chemotherapy (NAC) in GC is to downstage primary tumour, eliminate potential micrometastases, and increase the chance for radical r...

(This article belongs to the Special Issue Advanced Gastric Cancer)
  • Review
  • Open Access
12 Citations
4,862 Views
16 Pages

Bone Marrow Environment in Metastatic Neuroblastoma

  • Chiara Brignole,
  • Fabio Pastorino,
  • Patrizia Perri,
  • Loredana Amoroso and ,
  • Veronica Bensa,
  • Enzo Calarco,
  • Mirco Ponzoni and
  • Maria Valeria Corrias
  • + 3 authors+ 0 author

19 May 2021

The study of the interactions occurring in the BM environment has been facilitated by the peculiar nature of metastatic NB. In fact: (i) metastases are present at diagnosis; (ii) metastases are confined in a very specific tissue, the BM, suggestive o...

(This article belongs to the Special Issue The Tumor Microenvironment of Neuroblastoma)
  • Review
  • Open Access
44 Citations
8,001 Views
18 Pages

Current Treatment Options in CLL

  • Moritz Bewarder,
  • Stephan Stilgenbauer,
  • Lorenz Thurner and
  • Dominic Kaddu-Mulindwa

19 May 2021

After impressive developments in recent years with the rise of new targeted agents, chemoimmunotherapy (CIT) only plays a minor role in the treatment of patients with chronic lymphocytic leukemia (CLL). Inhibitors of the Bruton tyrosine kinase (BTK),...

(This article belongs to the Special Issue Novel Drug Targets and Advances in Treatment of CLL)
  • Review
  • Open Access
35 Citations
8,257 Views
25 Pages

Machine Learning and Radiomics Applications in Esophageal Cancers Using Non-Invasive Imaging Methods—A Critical Review of Literature

  • Chen-Yi Xie,
  • Chun-Lap Pang,
  • Benjamin Chan,
  • Emily Yuen-Yuen Wong and ,
  • Qi Dou and
  • Varut Vardhanabhuti
  • + 1 author+ 0 author

19 May 2021

Esophageal cancer (EC) is of public health significance as one of the leading causes of cancer death worldwide. Accurate staging, treatment planning and prognostication in EC patients are of vital importance. Recent advances in machine learning (ML)...

(This article belongs to the Special Issue Transformational Role of Medical Imaging in Oncology)
  • Article
  • Open Access
17 Citations
3,448 Views
13 Pages

Clinical, Histological, and Molecular Features of Solitary Fibrous Tumor of Bone: A Single Institution Retrospective Review

  • Giuseppe Bianchi,
  • Debora Lana,
  • Marco Gambarotti,
  • Cristina Ferrari and ,
  • Marta Sbaraglia,
  • Elena Pedrini,
  • Laura Pazzaglia,
  • Luca Sangiorgi,
  • Isabella Bartolotti and
  • Alberto Righi
  • + 7 authors+ 2 authors

19 May 2021

Primary solitary fibrous tumor (SFT) of the bone is extremely rare, with only few cases reported in the literature. We retrieved all cases of primary SFT of the bone treated at our institution and we assessed the morphology and the immunohistochemica...

(This article belongs to the Special Issue Solitary Fibrous Tumor)
  • Article
  • Open Access
4 Citations
2,976 Views
12 Pages

19 May 2021

(1) Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy provide survival benefits to selected patients. We aimed to report our experience and the evolution of our peritoneal surface malignancy program. (2) Methods: From Ju...

(This article belongs to the Special Issue Pathophysiology and Treatment of Peritoneal Metastasis)
  • Communication
  • Open Access
9 Citations
2,640 Views
7 Pages

Thymic Carcinomas and Second Malignancies: A Single-Center Review

  • Sunil S. Badve,
  • Rachel Dougherty,
  • Michael Balatico,
  • Kenneth A. Kesler and ,
  • Patrick Loehrer and
  • Yesim Gökmen-Polar
  • + 1 author+ 0 author

19 May 2021

Thymic carcinomas account for less than 0.01% of new cancer diagnoses annually and are more aggressive than thymomas. Autoimmune disorders have been associated with thymomas and only recently with thymic carcinomas. Second malignancies are well descr...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
14 Citations
4,724 Views
13 Pages

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models

  • Owen Hoare,
  • Nicolas Fraunhoffer,
  • Abdessamad Elkaoutari,
  • Odile Gayet and ,
  • Martin Bigonnet,
  • Julie Roques,
  • Rémy Nicolle,
  • Colin McGuckin,
  • Nico Forraz and
  • Nelson J. Dusetti
  • + 15 authors+ 10 authors

19 May 2021

Purpose: Compare pancreatic ductal adenocarcinoma (PDAC), preclinical models, by their transcriptome and drug response landscapes to evaluate their complementarity. Experimental Design: Three paired PDAC preclinical models—patient-derived xenografts...

  • Article
  • Open Access
29 Citations
4,428 Views
16 Pages

A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with IDH1-Mutated Solid Tumors

  • Mohammed Khurshed,
  • Remco J. Molenaar,
  • Myra E. van Linde,
  • Ron A. Mathôt and ,
  • Eduard A. Struys,
  • Tom van Wezel,
  • Cornelis J. F. van Noorden,
  • Heinz-Josef Klümpen,
  • Judith V. M. G. Bovée and
  • Johanna W. Wilmink
  • + 5 authors+ 0 author

19 May 2021

Background: Mutations in isocitrate dehydrogenase 1 (IDH1) occur in 60% of chondrosarcoma, 80% of WHO grade II-IV glioma and 20% of intrahepatic cholangiocarcinoma. These solid IDH1-mutated tumors produce the oncometabolite D-2-hydroxyglutarate (D-2H...

(This article belongs to the Special Issue Recurrent Glioblastoma)
  • Review
  • Open Access
36 Citations
6,486 Views
27 Pages

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis

  • George N. Tzanakakis,
  • Eirini-Maria Giatagana,
  • Aikaterini Berdiaki,
  • Ioanna Spyridaki and ,
  • Kyoko Hida,
  • Monica Neagu,
  • Aristidis M. Tsatsakis and
  • Dragana Nikitovic
  • + 3 authors+ 0 author

19 May 2021

Bone sarcomas, mesenchymal origin tumors, represent a substantial group of varying neoplasms of a distinct entity. Bone sarcoma patients show a limited response or do not respond to chemotherapy. Notably, developing efficient chemotherapy approaches,...

(This article belongs to the Collection Matrix Effectors and Cancer)
  • Article
  • Open Access
11 Citations
4,687 Views
13 Pages

COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients

  • Beth Russell,
  • Charlotte L. Moss,
  • Kieran Palmer,
  • Rushan Sylva and ,
  • Andrea D’Souza,
  • Harriet Wylie,
  • Anna Haire,
  • Fidelma Cahill,
  • Renee Steel and
  • Saoirse Dolly
  • + 27 authors+ 22 authors

19 May 2021

Very few studies investigating COVID-19 in cancer patients have included cancer patients as controls. We aimed to identify factors associated with the risk of testing positive for SARS CoV2 infection in a cohort of cancer patients. We analyzed data f...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
31 Citations
5,012 Views
13 Pages

Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation

  • Víctor Amado,
  • Sandra González-Rubio,
  • Javier Zamora,
  • Rafael Alejandre and ,
  • María Lola Espejo-Cruz,
  • Clara Linares,
  • Marina Sánchez-Frías,
  • Gema García-Jurado,
  • José Luis Montero and
  • Manuel De la Mata
  • + 8 authors+ 3 authors

19 May 2021

Background: In patients with hepatocellular carcinoma (HCC), a complete clearance of circulating tumor cells (CTCs) early after liver transplantation (LT) or surgical resection (LR) could prevent tumor recurrence. Methods: prospective pilot study inc...

(This article belongs to the Special Issue Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment)
  • Article
  • Open Access
10 Citations
3,467 Views
16 Pages

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model

  • Bleuenn Brusset,
  • Jerome Dumortier,
  • Daniel Cherqui,
  • Georges-Philippe Pageaux and ,
  • Emmanuel Boleslawski,
  • Ludivine Chapron,
  • Jean-Louis Quesada,
  • Sylvie Radenne,
  • Didier Samuel and
  • Thomas Decaens
  • + 7 authors+ 2 authors

19 May 2021

Purpose: To compare the agreement for the criteria on the explant and the results of liver transplantation (LT) before and after adoption of the AFP (α-fetoprotein) model. Methods: 523 patients consecutively listed in five French centers were reviewe...

(This article belongs to the Special Issue Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment)
  • Review
  • Open Access
84 Citations
6,807 Views
23 Pages

Enhancing Clinical Translation of Cancer Using Nanoinformatics

  • Madjid Soltani,
  • Farshad Moradi Kashkooli,
  • Mohammad Souri,
  • Samaneh Zare Harofte and ,
  • Tina Harati,
  • Atefeh Khadem,
  • Mohammad Haeri Pour and
  • Kaamran Raahemifar
  • + 3 authors+ 0 author

19 May 2021

Application of drugs in high doses has been required due to the limitations of no specificity, short circulation half-lives, as well as low bioavailability and solubility. Higher toxicity is the result of high dosage administration of drug molecules...

(This article belongs to the Collection Artificial Intelligence in Oncology)
  • Systematic Review
  • Open Access
13 Citations
7,687 Views
12 Pages

Impact of Previous Irradiation on Wound Healing after Negative Pressure Wound Therapy in Head and Neck Cancer Patients—A Systematic Review

  • Muhammad Faisal,
  • Peter D. Berend,
  • Rudolf Seemann,
  • Stefan Janik and ,
  • Stefan Grasl,
  • Andrea Ritzengruber,
  • Herbert Mendel,
  • Arif Jamshed,
  • Raza Hussain and
  • Boban M. Erovic
  • + 5 authors+ 0 author

19 May 2021

(1) Background: Negative pressure wound therapy (NPWT) has been effectively used for wound management in comparison to traditional dressings. The purpose of this study was to provide an evidence-based review of NPWT in head and neck cancer patients,...

(This article belongs to the Special Issue Surgical Treatment of Head and Neck Squamous Cell Carcinomas (HNSCC))
  • Review
  • Open Access
76 Citations
12,975 Views
20 Pages

19 May 2021

Sphingolipids are bioactive lipids responsible for regulating diverse cellular functions such as proliferation, migration, senescence, and death. These lipids are characterized by a long-chain sphingosine backbone amide-linked to a fatty acyl chain w...

(This article belongs to the Special Issue The Role of Ceramide Synthases in Cancers)
  • Communication
  • Open Access
15 Citations
3,706 Views
10 Pages

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity

  • Sophie Deneuve,
  • Céline Mirjolet,
  • Thierry Bastogne,
  • Mirlande Duclos and ,
  • Paul Retif,
  • Philippe Zrounba,
  • Pierre-Eric Roux,
  • Marc Poupart,
  • Guillaume Vogin and
  • Sandrine Pereira
  • + 6 authors+ 1 author

19 May 2021

Radiation therapy (RT), either alone or in combination with surgery and/or chemotherapy is a keystone of cancers treatment. Early toxicity is common, sometimes leading to discontinuation of treatment. Recent studies stressed the role of the phosphory...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
14 Citations
3,758 Views
16 Pages

Multimodal Imaging Techniques to Evaluate the Anticancer Effect of Cold Atmospheric Pressure Plasma

  • Marcel Kordt,
  • Isabell Trautmann,
  • Christin Schlie,
  • Tobias Lindner and ,
  • Jan Stenzel,
  • Anna Schildt,
  • Lars Boeckmann,
  • Sander Bekeschus,
  • Jens Kurth and
  • Eberhard Grambow
  • + 7 authors+ 2 authors

19 May 2021

Background: Skin cancer is the most frequent cancer worldwide and is divided into non-melanoma skin cancer, including basal cell carcinoma, as well as squamous cell carcinoma (SCC) and malignant melanoma (MM). Methods: This study evaluates the effect...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
47 Citations
4,946 Views
17 Pages

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients

  • Thorben Fründt,
  • Linda Krause,
  • Elaine Hussey,
  • Bettina Steinbach and ,
  • Daniel Köhler,
  • Johann von Felden,
  • Kornelius Schulze,
  • Ansgar W. Lohse,
  • Henning Wege and
  • Heidi Schwarzenbach
  • + 5 authors+ 0 author

19 May 2021

We aimed to identify a specific microRNA (miRNA) pattern to determine diagnostic and prognostic value in plasma exosomes of hepatocellular carcinoma (HCC) patients. A two-stage study was carried out: exosomal miRNAs were quantified in plasma of HCC p...

(This article belongs to the Special Issue Primary Hepatobiliary Tumor)
  • Review
  • Open Access
23 Citations
5,976 Views
22 Pages

19 May 2021

Hepatitis C virus (HCV) genome encodes for one long polyprotein that is processed by cellular and viral proteases to generate 10 polypeptides. The viral structural proteins include the core protein, and the envelope glycoproteins E1 and E2, present a...

(This article belongs to the Special Issue Hepatitis C Virus and Hepatocellular Carcinoma (HCV & HCC))
  • Review
  • Open Access
31 Citations
6,447 Views
16 Pages

18 May 2021

Generally, patients with pancreatic ductal adenocarcinoma, especially those with wide metastatic lesions, have a poor prognosis. Recently, a breakthrough in improving their survival has been achieved by using first-line chemotherapy, such as gemcitab...

(This article belongs to the Special Issue Tumor Microenvironment of Pancreatic Cancer)
  • Article
  • Open Access
6 Citations
5,951 Views
13 Pages

Familial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants

  • Joline F. Roze,
  • Joachim Kutzera,
  • Wouter Koole,
  • Margreet G. E. M. Ausems and ,
  • Kristi Engelstad,
  • Jurgen M. J. Piek,
  • Cor D. de Kroon,
  • René H. M. Verheijen,
  • Gijs van Haaften and
  • Glen R. Monroe
  • + 6 authors+ 1 author

18 May 2021

Adult granulosa cell tumor (AGCT) is a rare ovarian cancer subtype, with a peak incidence around 50–55 years. Although AGCT can occur in specific syndromes, a genetic predisposition for AGCT has not been identified. The aim of this study is to identi...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
31 Citations
3,631 Views
10 Pages

Iodine Map Radiomics in Breast Cancer: Prediction of Metastatic Status

  • Lukas Lenga,
  • Simon Bernatz,
  • Simon S. Martin,
  • Christian Booz and ,
  • Christine Solbach,
  • Rotraud Mulert-Ernst,
  • Thomas J. Vogl and
  • Doris Leithner
  • + 3 authors+ 0 author

18 May 2021

Dual-energy CT (DECT) iodine maps enable quantification of iodine concentrations as a marker for tissue vascularization. We investigated whether iodine map radiomic features derived from staging DECT enable prediction of breast cancer metastatic stat...

(This article belongs to the Special Issue Clinical Studies on Imaging Biomarkers)
  • Article
  • Open Access
2 Citations
3,366 Views
13 Pages

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups

  • Anna Mueller-Schoell,
  • Robin Michelet,
  • Lena Klopp-Schulze,
  • Madelé van Dyk and ,
  • Thomas E. Mürdter,
  • Matthias Schwab,
  • Markus Joerger,
  • Wilhelm Huisinga,
  • Gerd Mikus and
  • Charlotte Kloft
  • + 5 authors+ 0 author

18 May 2021

Tamoxifen is used worldwide to treat estrogen receptor-positive breast cancer. It is extensively metabolized, and minimum steady-state concentrations of its metabolite endoxifen (CSS,min ENDX) >5.97 ng/mL have been associated with favorable outcom...

(This article belongs to the Special Issue Pharmacokinetics/Pharmacodynamics/Pharmacogenetics Based Personalized Medicine for Cancer Therapy)
  • Article
  • Open Access
14 Citations
2,874 Views
13 Pages

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables

  • Paolo Gandellini,
  • Chiara Maura Ciniselli,
  • Tiziana Rancati,
  • Cristina Marenghi and ,
  • Valentina Doldi,
  • Rihan El Bezawy,
  • Mara Lecchi,
  • Melanie Claps,
  • Mario Catanzaro and
  • Nadia Zaffaroni
  • + 11 authors+ 6 authors

18 May 2021

Active surveillance (AS) has evolved as a strategy alternative to radical treatments for very low risk and low-risk prostate cancer (PCa). However, current criteria for selecting AS patients are still suboptimal. Here, we performed an unprecedented a...

(This article belongs to the Special Issue Non-Coding RNAs in Urological Malignancies: Relevance for Tumorigenesis and Biomarker Development)
  • Review
  • Open Access
35 Citations
6,365 Views
15 Pages

18 May 2021

For endometrial cancer, a new classification is now available from ESMO, ESGO, and ESTRO based on clinical and molecular characteristics to determine adjuvant therapy. The contribution of molecular biology is major for this pathology mainly by the in...

(This article belongs to the Special Issue Microsatellite Instability and Cancers)
  • Systematic Review
  • Open Access
17 Citations
4,756 Views
16 Pages

18 May 2021

Cancer stem cells (CSCs) have increasingly been shown to be a crucial element of heterogenous tumors. Although a relatively small component of the population, they increase the resistance to treatment and the likelihood of recurrence. In recent years...

(This article belongs to the Special Issue Stemness and Differentiation in Cancer)
  • Review
  • Open Access
52 Citations
5,930 Views
19 Pages

Radiomics in Differentiated Thyroid Cancer and Nodules: Explorations, Application, and Limitations

  • Yuan Cao,
  • Xiao Zhong,
  • Wei Diao,
  • Jingshi Mu and ,
  • Yue Cheng and
  • Zhiyun Jia
  • + 1 author+ 0 author

18 May 2021

Radiomics is an emerging technique that allows the quantitative extraction of high-throughput features from single or multiple medical images, which cannot be observed directly with the naked eye, and then applies to machine learning approaches to co...

(This article belongs to the Special Issue Advances in the Diagnosis and Treatment of Thyroid Carcinoma)
  • Article
  • Open Access
18 Citations
5,052 Views
19 Pages

Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses

  • Sang R. Lee,
  • Jong Geol Lee,
  • Jun H. Heo,
  • Seong Lae Jo and ,
  • Jihoon Ryu,
  • Globinna Kim,
  • Jung-Min Yon,
  • Myeong Sup Lee,
  • Geun-Shik Lee and
  • Eui-Ju Hong
  • + 9 authors+ 4 authors

18 May 2021

Pgrmc1 is a non-canonical progesterone receptor related to the lethality of various types of cancer. PGRMC1 has been reported to exist in co-precipitated protein complexes with epidermal growth factor receptor (EGFR), which is considered a useful the...

(This article belongs to the Special Issue The Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology)
  • Article
  • Open Access
19 Citations
4,083 Views
19 Pages

Differential Effect of Non-Thermal Plasma RONS on Two Human Leukemic Cell Populations

  • Hager Mohamed,
  • Eric Gebski,
  • Rufranshell Reyes,
  • Samuel Beane and ,
  • Brian Wigdahl,
  • Fred C. Krebs,
  • Katharina Stapelmann and
  • Vandana Miller
  • + 3 authors+ 0 author

18 May 2021

Non-thermal plasma application to cancer cells is known to induce oxidative stress, cytotoxicity and indirect immunostimulatory effects on antigen presenting cells (APCs). The purpose of this study was to evaluate the responses of two leukemic cell l...

(This article belongs to the Special Issue Advances in Plasma Oncology toward Clinical Translation)

of 5

XFacebookLinkedIn
Cancers - ISSN 2072-6694